首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
PembrolizumabLack of efficacy: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2022年
/ 1922卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-022-22768-9
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:483 / 483
相关论文
共 50 条
[41]
Entinostat/pembrolizumabLack of efficacy: case report
Reactions Weekly,
2023,
1938
(1)
: 595
-
595
[42]
Nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly,
2025,
2040
(1)
: 759
-
759
[43]
Nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly,
2022,
1935
(1)
: 347
-
347
[44]
Dacarbazine/pembrolizumabLack of efficacy : case report
Reactions Weekly,
2024,
2020
(1)
: 170
-
170
[45]
Dexamethasone/pembrolizumabLack of efficacy: case report
Reactions Weekly,
2023,
1970
(1)
: 116
-
116
[46]
PembrolizumabLack of efficacy and hypothyroidism: case report
Reactions Weekly,
2023,
1950
(1)
: 330
-
330
[47]
Cabozantinib/pembrolizumabLack of efficacy: case report
Reactions Weekly,
2025,
2041
(1)
: 92
-
92
[48]
Antineoplastics/pembrolizumabLack of efficacy: case report
Reactions Weekly,
2022,
1919
(1)
: 91
-
91
[49]
Paclitaxel/pembrolizumabLack of efficacy: case report
Reactions Weekly,
2022,
1918
(1)
: 403
-
403
[50]
Carboplatin/gemcitabine/pembrolizumabLack of efficacy: case report
Reactions Weekly,
2023,
1959
(1)
: 176
-
176
←
1
2
3
4
5
→